Sudipta Basu

2.2k total citations
75 papers, 1.7k citations indexed

About

Sudipta Basu is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Sudipta Basu has authored 75 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 27 papers in Biomedical Engineering and 16 papers in Biomaterials. Recurrent topics in Sudipta Basu's work include Nanoplatforms for cancer theranostics (18 papers), Nanoparticle-Based Drug Delivery (16 papers) and Graphene and Nanomaterials Applications (11 papers). Sudipta Basu is often cited by papers focused on Nanoplatforms for cancer theranostics (18 papers), Nanoparticle-Based Drug Delivery (16 papers) and Graphene and Nanomaterials Applications (11 papers). Sudipta Basu collaborates with scholars based in India, United States and Germany. Sudipta Basu's co-authors include Abhik Mallick, Shiladitya Sengupta, Herbert Waldmann, Rania Harfouche, Piyush More, Poulomi Sengupta, R. A. Mashelkar, Shivani Soni, Eleni Gourzoulidou and Мarcus A. Koch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and PLoS ONE.

In The Last Decade

Sudipta Basu

70 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sudipta Basu India	23	732	421	375	356	349	75	1.7k
Yongtao Duan China	22	836 1.1×	220 0.5×	187 0.5×	708 2.0×	206 0.6×	107	2.1k
Ziad Omran Saudi Arabia	17	650 0.9×	459 1.1×	459 1.2×	126 0.4×	263 0.8×	46	1.5k
Jinha Yu South Korea	22	764 1.0×	258 0.6×	264 0.7×	293 0.8×	429 1.2×	61	1.9k
Loretta Lazzarato Italy	27	691 0.9×	343 0.8×	164 0.4×	689 1.9×	231 0.7×	89	2.4k
Mehdi Rajabi United States	21	960 1.3×	214 0.5×	205 0.5×	420 1.2×	101 0.3×	54	1.9k
Lin Wei China	16	557 0.8×	151 0.4×	176 0.5×	499 1.4×	208 0.6×	44	1.2k
Xiangming Guan United States	22	1.1k 1.5×	237 0.6×	87 0.2×	239 0.7×	173 0.5×	45	2.2k
Chinpiao Chen Taiwan	25	584 0.8×	208 0.5×	111 0.3×	1.3k 3.7×	340 1.0×	96	2.2k
Manu Jaggi India	30	1.3k 1.8×	209 0.5×	409 1.1×	940 2.6×	90 0.3×	78	3.1k
Yueqing Li China	21	598 0.8×	631 1.5×	85 0.2×	220 0.6×	497 1.4×	75	1.7k

Countries citing papers authored by Sudipta Basu

Since Specialization

Citations

This map shows the geographic impact of Sudipta Basu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sudipta Basu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sudipta Basu more than expected).

Fields of papers citing papers by Sudipta Basu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sudipta Basu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sudipta Basu. The network helps show where Sudipta Basu may publish in the future.

Co-authorship network of co-authors of Sudipta Basu

This figure shows the co-authorship network connecting the top 25 collaborators of Sudipta Basu. A scholar is included among the top collaborators of Sudipta Basu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sudipta Basu. Sudipta Basu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Prasanna, Radha, et al.. (2025). Beneficial cyanobacteria as seed coatings to enhance the storability and viability indices of spinach seeds. Biocatalysis and Agricultural Biotechnology. 70. 103844–103844.

Mondal, Anirban, et al.. (2024). Imaging Golgi‐Apparatus in Colon Cancer Cells by Small Molecule Hydrazone Fluorophore. ChemBioChem. 25(22). 1 indexed citations

Mishra, Tripti, et al.. (2024). Detouring NSAID into Mitochondria to Induce Apoptosis in Cancer Cells. Chemistry - An Asian Journal. 19(23). e202400732–e202400732.

Mishra, Tripti, Poulomi Sengupta, & Sudipta Basu. (2024). Biomaterials for Targeting Endoplasmic Reticulum in Cancer. Chemistry - An Asian Journal. 19(11). e202400250–e202400250. 2 indexed citations

Mondal, Anirban, et al.. (2023). Small Molecule AIEgens for Illuminating Sub‐Cellular Endoplasmic Reticulum, Mitochondria, and Lysosomes**. ChemBioChem. 24(19). e202300379–e202300379. 2 indexed citations

Kumar, Mahesh, et al.. (2023). 3‐Methoxy‐Pyrrole‐Based Small Molecule Damages Mitochondria to Instigate Apoptosis in Breast Cancer Cells. ChemistrySelect. 8(24). 1 indexed citations

Basu, Sudipta, et al.. (2023). Small‐Molecule Endoplasmic Reticulum Stress Inducer Triggers Apoptosis in Cancer Cells. ChemMedChem. 18(24). e202300433–e202300433. 1 indexed citations

Khatua, Saumyakanti, et al.. (2023). Dog-bone shaped gold nanoparticle-mediated chemo-photothermal therapy impairs the powerhouse to trigger apoptosis in cancer cells. Journal of Materials Chemistry B. 11(40). 9732–9741. 12 indexed citations

Roy, Sudip, et al.. (2017). Drug-Triggered Self-Assembly of Linear Polymer into Nanoparticles for Simultaneous Delivery of Hydrophobic and Hydrophilic Drugs in Breast Cancer Cells. ACS Omega. 2(12). 8730–8740. 12 indexed citations

10.

Basu, Sudipta, et al.. (2016). Biological Activity of Coumarin Derivatives as Anti-Leishmanial Agents. PLoS ONE. 11(10). e0164585–e0164585. 44 indexed citations

11.

Basu, Sudipta, et al.. (2016). Loading of an anti-cancer drug into mesoporous silica nano-channels and its subsequent release to DNA. Nanoscale. 8(43). 18436–18445. 19 indexed citations

12.

Basu, Sudipta & Herbert Waldmann. (2014). Polymer supported synthesis of a natural product-inspired oxepane library. Bioorganic & Medicinal Chemistry. 22(16). 4430–4444. 8 indexed citations

13.

Ravindran, Selvan, et al.. (2014). Metabolite Characterization of Anti-cancer Agent Gefitinib in Human Hepatocytes. Drug Metabolism Letters. 7(2). 126–136. 7 indexed citations

14.

Pandey, Ambarish, Ashish Kulkarni, Bhaskar Roy, et al.. (2013). Sequential Application of a Cytotoxic Nanoparticle and a PI3K Inhibitor Enhances Antitumor Efficacy. Cancer Research. 74(3). 675–685. 27 indexed citations

15.

Kulkarni, Ashish, Bhaskar Roy, Gregory A. Wyant, et al.. (2013). Supramolecular Nanoparticles That Target Phosphoinositide-3-Kinase Overcome Insulin Resistance and Exert Pronounced Antitumor Efficacy. Cancer Research. 73(23). 6987–6997. 20 indexed citations

16.

Sarangi, Sasmit, et al.. (2013). P2Y12 receptor inhibition augments cytotoxic effects of cisplatin in breast cancer. Medical Oncology. 30(2). 567–567. 24 indexed citations

17.

Patil, Sumersing, et al.. (2013). Synthesis, characterization and in vitro evaluation of novel vitamin D3 nanoparticles as a versatile platform for drug delivery in cancer therapy. Journal of Materials Chemistry B. 1(42). 5742–5742. 14 indexed citations

18.

Sengupta, Poulomi, Sudipta Basu, & Shiladitya Sengupta. (2011). Cancer, Signal Transduction and Nanotechnology. Current Drug Delivery. 8(3). 254–260. 1 indexed citations

19.

Harfouche, Rania, Sudipta Basu, Shivani Soni, et al.. (2009). Nanoparticle-mediated targeting of phosphatidylinositol-3-kinase signaling inhibits angiogenesis. Angiogenesis. 12(4). 325–338. 76 indexed citations

20.

Basu, Sudipta, Padmaparna Chaudhuri, & Shiladitya Sengupta. (2009). Targeting oncogenic signaling pathways by exploiting nanotechnology. Cell Cycle. 8(21). 3480–3487. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact